Best Growth Stocks to Buy for March 27th

DraftKings’ bulls were thrown an unexpected curveball, but this new competition doesn’t carry the same brand-name cache. After years of development, Recursion Pharmaceuticals’ AI-powered drug discovery technology should finally, firmly start proving its true value.

A surge in the price of fertilizer is sending shares of U.S. producers soaring, while forcing farmers into tough choices ahead of spring planting.

Generic drugmakers face pricing pressure, but companies like TEVA, SDZNY and RDY are betting on complex generics and biosimilars to protect growth.